Pfizer to appeal over India drug patent refusal AFP Indian generics drugs heavyweight Cipla teamed up with other generic local pharmaceutical companies to oppose the granting of the domestic patent for Sutent, which is used to fight liver and kidney cancer. The decision went to the heart of India's ... |
